Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:drug |
| gptkbp:approvalYear |
2009
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
B06AC05
|
| gptkbp:brand |
Kalbitor
|
| gptkbp:CASNumber |
570417-26-2
|
| gptkbp:developer |
Dyax
|
| gptkbp:hasMolecularFormula |
C269H408N72O78S6
|
| https://www.w3.org/2000/01/rdf-schema#label |
ecallantide
|
| gptkbp:indication |
acute attacks of hereditary angioedema
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
plasma kallikrein inhibitor
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
nausea
diarrhea headache anaphylaxis |
| gptkbp:UNII |
Q1U8A8V977
|
| gptkbp:usedFor |
gptkb:hereditary_hemorrhagic_telangiectasia
|
| gptkbp:bfsParent |
gptkb:hereditary_hemorrhagic_telangiectasia
|
| gptkbp:bfsLayer |
6
|